DNA X, Inc. (SONM) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $1.30M | -75.6% |
| 2024 | $5.34M | -43.1% |
| 2023 | $9.40M | -28.9% |
| 2022 | $13.21M | +17.6% |
| 2021 | $11.23M | -49.3% |
| 2020 | $22.14M | +96.0% |
| 2019 | $11.30M | -13.4% |
| 2018 | $13.05M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $1.30M | -75.6% |
| 2024 | $5.34M | -43.1% |
| 2023 | $9.40M | -28.9% |
| 2022 | $13.21M | +17.6% |
| 2021 | $11.23M | -49.3% |
| 2020 | $22.14M | +96.0% |
| 2019 | $11.30M | -13.4% |
| 2018 | $13.05M | — |